Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK gets new head of patient safety as medical technology comes under media spotlight

This article was originally published in Clinica

Executive Summary

The service quality and patient safety elements of the UK's healthcare reforms will soon be the responsibility of Professor Martin Marshall, following his appointment as deputy chief medical officer. The medical technology industry has a vested interest in ensuring that he does a good job when he takes up his post on May 15, but, in the meantime, Clinica notes an apparent shift in policy on risk-management in relation to technological innovation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT051196

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel